Alternatives to Traditional Flu Vaccines for Individuals with Egg Allergies

Available Egg-Free and Low-Egg Options

The Centers for Disease Control and Prevention recommends recombinant influenza vaccine (RIV) as the preferred option for individuals with egg allergies, as it is completely egg-free 1, 2
RIV is indicated for persons aged 18 through 49 years (original FluBlok) or ≥18 years (newer quadrivalent formulation) 3, 4
Cell Culture-Based Inactivated Influenza Vaccine (ccIIV) is another suitable alternative with minimal theoretical egg protein content, containing extremely minimal theoretical egg protein (maximum of 1.7×10-8 μg/0.5 mL dose) 2, 5
ccIIV is indicated for persons aged ≥18 years (original trivalent version) or ≥4 years (quadrivalent version) 4, 6

For patients with a history of only hives after egg exposure, any age-appropriate influenza vaccine can be administered without special precautions, according to the Centers for Disease Control and Prevention 1, 2
For patients with more severe egg allergy reactions, any age-appropriate influenza vaccine can still be used, including egg-based vaccines, but administration should occur in an inpatient or outpatient medical setting with supervision by healthcare providers able to recognize and manage severe allergic reactions 1, 2

A previous severe allergic reaction to influenza vaccine itself is a contraindication to future receipt of the vaccine, as stated by the Centers for Disease Control and Prevention 2, 7
For persons with no known history of egg exposure but with positive allergy testing results, consultation with an allergist is recommended before vaccination, according to the Centers for Disease Control and Prevention 4
All vaccine providers should be familiar with their office emergency plan and be certified in cardiopulmonary resuscitation, as recommended by the Centers for Disease Control and Prevention 2, 5

The Centers for Disease Control and Prevention recommends that any licensed and recommended influenza vaccine that is otherwise appropriate for the recipient's age and health status may be used for a patient with a history of hives after egg exposure 8, 9, 10
Patients with egg allergy can be categorized based on their reaction severity, with those who have experienced only urticaria (hives) after egg exposure being eligible for any age-appropriate influenza vaccine 9, 10
For patients who have experienced only hives after egg exposure, any age-appropriate, licensed influenza vaccine can be administered without special precautions beyond those recommended for any vaccine 8, 9, 10, 11
The American Academy of Pediatrics and other guideline societies support the administration of influenza vaccines to egg-allergic individuals, with precautions for those with more severe reactions 9, 11

Inactivated influenza vaccines (IIVs) contain small amounts of egg protein, while recombinant influenza vaccine (RIV) is manufactured without the use of eggs and does not carry a contraindication for egg allergy 11, 12
No specific post-vaccination observation period is recommended for egg-allergic persons beyond the standard 15-minute observation recommended for all vaccines 9, 11
No skin testing is required before administering the vaccine to patients with a history of only hives after egg exposure 9, 11, 13

Unnecessarily delaying vaccination due to egg allergy concerns is a common pitfall, and any age-appropriate vaccine would be suitable for patients with only a history of hives after egg exposure 9, 11

Flucelvax is manufactured using mammalian cell culture rather than embryonated eggs, which fundamentally distinguishes it from traditional egg-based vaccines 14
The theoretical maximum egg protein content in Flucelvax is 5×10⁻⁸ μg per 0.5 mL dose, making it essentially egg-free in practical terms, and several orders of magnitude lower than traditional egg-based vaccines, which contain ≤1 μg/0.5 mL 15, 16
This is approximately 20 million times less egg protein than standard inactivated influenza vaccines 15

For patients with mild egg allergy, the Centers for Disease Control and Prevention (CDC) recommends administering any age-appropriate influenza vaccine, including Flucelvax, without special precautions beyond standard vaccination protocols 15, 17
The vaccine should be given in a setting where personnel and equipment for managing anaphylaxis are available, as with all vaccines 15, 17

A systematic review of 4,172 patients, including 513 with severe egg allergy, found no occurrences of anaphylaxis to influenza vaccines, though some mild reactions occurred 15, 16
VAERS surveillance data from 2011-2013 showed no disproportionate reporting of allergic reactions or anaphylaxis following implementation of liberalized egg allergy recommendations 15, 18

The American Academy of Pediatrics and the CDC recommend that any licensed, age-appropriate influenza vaccine can be administered to patients with egg allergy, regardless of severity, without special precautions beyond standard vaccination protocols, although this may not be explicitly stated in the provided text, it is implied through the context of the recommendations 15
Ensure all vaccination providers are familiar with office emergency plans and certified in CPR, as with all vaccine administration 14